Infect Dis:坦桑尼亚城市成人结核病患者具有明显的临床特征和蠕虫混合感染

2018-05-30 MedSci MedSci原创

农村和城市环境的差异能够解释结核病的流行病学特征。我们对坦桑尼亚农村和城市成年结核病患者和蠕虫共感染的流行病学特征进行了比较研究。 研究人员分别在在人口为~ 440万居民(城市)的达累斯萨拉姆,以及在人口为~ 400000居民(农村)的Ifakara人烟稀少的地区基隆贝罗招募两个队列研究。成年患者(≥18年)通过微生物学确诊为肺结核,并在招募时同时获得临床资料。粪便和尿样通过改良加藤法、Ba

农村和城市环境的差异能够解释结核病的流行病学特征。我们对坦桑尼亚农村和城市成年结核病患者和蠕虫共感染的流行病学特征进行了比较研究。

研究人员分别在在人口为~ 440万居民(城市)的达累斯萨拉姆,以及在人口为~ 400000居民(农村)的Ifakara人烟稀少的地区基隆贝罗招募两个队列研究。成年患者(18)通过微生物学确诊为肺结核,并在招募时同时获得临床资料。粪便和尿样通过改良加藤法、Baermann、尿液过滤和循环阴极抗原检测来诊断蠕虫感染。通过χ2检验,费舍尔确切概率,Wilcoxon等级评估组间差异,使用逻辑回归模型来确定相互关联。

20158月至20172月期间,总共登记668名患者,其中,460(68.9%)在城市,208(31.1%)在农村。中位患者年龄为35(四分位间距 [IQR]: 27-41.5),男性为454(68%)。与坦桑尼亚城市患者相比,农村患者年龄较大(平均年龄37vs34P = 0.003),平均身体质量指数较低(17.5 kg / m2 vs. 18.5 kg / m2P < 0.001),复发性结核病例比例较高(9% vs. 1%,P < 0.001)。艾滋病/结核病合并感染患者的中位数CD4细胞计数较低(147细胞/µl vs 249细胞/µlP = 0.02)。然而在两组间艾滋病毒感染的频率、糖尿病和血红蛋白浓度没有显著差异。蠕虫混合感染的总体患病率为22.9%95%置信区间[CI]: 20.4-27.0%)。在城市地区,蠕虫感染的发生率显著较高(25.7% vs. 17.3% P = 0.018),主要是粪类圆线虫(17.0% vs 4.8% P < 0.001)和血吸虫感染(4.1%16.4%P < 0.001)所导致的。复发性结核与患者生活在农村(调整优势比[aOR]: 3.97, 95% CI: 1.16-13.67)和年龄增加(aOR: 1.06, 95% CI: 1.02-1.10)有关。

在坦桑尼亚城市和农村地区,结核病患者的临床特征和蠕虫混合感染模式不同。这些差异强调了需要制定对应的公共卫生干预措施以改善结核病和混合感染的临床管理

原始出处:

George Sikalengo, Jerry Hella, et. al. Distinct clinical characteristics and helminth co-infections in adult tuberculosis patients from urban compared to rural Tanzania

本文系梅斯医学MedSci原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1957497, encodeId=156c195e4973f, content=<a href='/topic/show?id=6a904149e51' target=_blank style='color:#2F92EE;'>#坦桑尼亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41497, encryptionId=6a904149e51, topicName=坦桑尼亚)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Nov 09 22:17:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012689, encodeId=0ba1201268984, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 17 22:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78654, encryptionId=6b49e865466, topicName=结核病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf9935672064, createdName=木头人525, createdTime=Fri Jan 04 02:17:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842879, encodeId=be7f18428e91d, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Jan 16 06:17:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1694364, encodeId=38ef16943644f, content=<a href='/topic/show?id=12688890867' target=_blank style='color:#2F92EE;'>#蠕虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88908, encryptionId=12688890867, topicName=蠕虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20d629606482, createdName=smlt2018, createdTime=Sun Feb 03 00:17:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321437, encodeId=852b32143ed5, content=学习了.获益匪浅.感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Jun 04 11:11:57 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254177, encodeId=7df312541e7a7, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 01 08:17:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1957497, encodeId=156c195e4973f, content=<a href='/topic/show?id=6a904149e51' target=_blank style='color:#2F92EE;'>#坦桑尼亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41497, encryptionId=6a904149e51, topicName=坦桑尼亚)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Nov 09 22:17:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012689, encodeId=0ba1201268984, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 17 22:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78654, encryptionId=6b49e865466, topicName=结核病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf9935672064, createdName=木头人525, createdTime=Fri Jan 04 02:17:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842879, encodeId=be7f18428e91d, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Jan 16 06:17:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1694364, encodeId=38ef16943644f, content=<a href='/topic/show?id=12688890867' target=_blank style='color:#2F92EE;'>#蠕虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88908, encryptionId=12688890867, topicName=蠕虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20d629606482, createdName=smlt2018, createdTime=Sun Feb 03 00:17:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321437, encodeId=852b32143ed5, content=学习了.获益匪浅.感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Jun 04 11:11:57 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254177, encodeId=7df312541e7a7, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 01 08:17:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1957497, encodeId=156c195e4973f, content=<a href='/topic/show?id=6a904149e51' target=_blank style='color:#2F92EE;'>#坦桑尼亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41497, encryptionId=6a904149e51, topicName=坦桑尼亚)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Nov 09 22:17:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012689, encodeId=0ba1201268984, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 17 22:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78654, encryptionId=6b49e865466, topicName=结核病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf9935672064, createdName=木头人525, createdTime=Fri Jan 04 02:17:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842879, encodeId=be7f18428e91d, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Jan 16 06:17:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1694364, encodeId=38ef16943644f, content=<a href='/topic/show?id=12688890867' target=_blank style='color:#2F92EE;'>#蠕虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88908, encryptionId=12688890867, topicName=蠕虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20d629606482, createdName=smlt2018, createdTime=Sun Feb 03 00:17:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321437, encodeId=852b32143ed5, content=学习了.获益匪浅.感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Jun 04 11:11:57 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254177, encodeId=7df312541e7a7, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 01 08:17:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1957497, encodeId=156c195e4973f, content=<a href='/topic/show?id=6a904149e51' target=_blank style='color:#2F92EE;'>#坦桑尼亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41497, encryptionId=6a904149e51, topicName=坦桑尼亚)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Nov 09 22:17:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012689, encodeId=0ba1201268984, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 17 22:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78654, encryptionId=6b49e865466, topicName=结核病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf9935672064, createdName=木头人525, createdTime=Fri Jan 04 02:17:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842879, encodeId=be7f18428e91d, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Jan 16 06:17:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1694364, encodeId=38ef16943644f, content=<a href='/topic/show?id=12688890867' target=_blank style='color:#2F92EE;'>#蠕虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88908, encryptionId=12688890867, topicName=蠕虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20d629606482, createdName=smlt2018, createdTime=Sun Feb 03 00:17:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321437, encodeId=852b32143ed5, content=学习了.获益匪浅.感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Jun 04 11:11:57 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254177, encodeId=7df312541e7a7, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 01 08:17:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1957497, encodeId=156c195e4973f, content=<a href='/topic/show?id=6a904149e51' target=_blank style='color:#2F92EE;'>#坦桑尼亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41497, encryptionId=6a904149e51, topicName=坦桑尼亚)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Nov 09 22:17:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012689, encodeId=0ba1201268984, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 17 22:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78654, encryptionId=6b49e865466, topicName=结核病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf9935672064, createdName=木头人525, createdTime=Fri Jan 04 02:17:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842879, encodeId=be7f18428e91d, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Jan 16 06:17:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1694364, encodeId=38ef16943644f, content=<a href='/topic/show?id=12688890867' target=_blank style='color:#2F92EE;'>#蠕虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88908, encryptionId=12688890867, topicName=蠕虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20d629606482, createdName=smlt2018, createdTime=Sun Feb 03 00:17:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321437, encodeId=852b32143ed5, content=学习了.获益匪浅.感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Jun 04 11:11:57 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254177, encodeId=7df312541e7a7, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 01 08:17:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2019-02-03 smlt2018
  6. [GetPortalCommentsPageByObjectIdResponse(id=1957497, encodeId=156c195e4973f, content=<a href='/topic/show?id=6a904149e51' target=_blank style='color:#2F92EE;'>#坦桑尼亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41497, encryptionId=6a904149e51, topicName=坦桑尼亚)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Nov 09 22:17:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012689, encodeId=0ba1201268984, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 17 22:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78654, encryptionId=6b49e865466, topicName=结核病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf9935672064, createdName=木头人525, createdTime=Fri Jan 04 02:17:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842879, encodeId=be7f18428e91d, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Jan 16 06:17:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1694364, encodeId=38ef16943644f, content=<a href='/topic/show?id=12688890867' target=_blank style='color:#2F92EE;'>#蠕虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88908, encryptionId=12688890867, topicName=蠕虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20d629606482, createdName=smlt2018, createdTime=Sun Feb 03 00:17:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321437, encodeId=852b32143ed5, content=学习了.获益匪浅.感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Jun 04 11:11:57 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254177, encodeId=7df312541e7a7, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 01 08:17:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-04 虈亣靌

    学习了.获益匪浅.感谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1957497, encodeId=156c195e4973f, content=<a href='/topic/show?id=6a904149e51' target=_blank style='color:#2F92EE;'>#坦桑尼亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41497, encryptionId=6a904149e51, topicName=坦桑尼亚)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Nov 09 22:17:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012689, encodeId=0ba1201268984, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 17 22:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78654, encryptionId=6b49e865466, topicName=结核病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf9935672064, createdName=木头人525, createdTime=Fri Jan 04 02:17:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842879, encodeId=be7f18428e91d, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Jan 16 06:17:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1694364, encodeId=38ef16943644f, content=<a href='/topic/show?id=12688890867' target=_blank style='color:#2F92EE;'>#蠕虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88908, encryptionId=12688890867, topicName=蠕虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20d629606482, createdName=smlt2018, createdTime=Sun Feb 03 00:17:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321437, encodeId=852b32143ed5, content=学习了.获益匪浅.感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Jun 04 11:11:57 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254177, encodeId=7df312541e7a7, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 01 08:17:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]

相关资讯

Lancet Respir Med:全球结核病流行与护理、预防和研究进展概述

结核病是全球传染病首位死亡原因,在世界结核日(2018年3月24日),提供了最新的结核病流行状况评估、推荐的诊断、药物治疗和疫苗、护理和预防工作的进展情况,研究和发展进展以及加速进展所需的行动。

在结核病门诊吸烟,温州一医生被全院通报批评罚款200元

在结核病患者就诊时,一名医生却在门诊室内抽烟——记者21日从浙江温州泰顺县人民医院了解到,该院已对涉事医生进行批评教育,并作出全院通报、罚款200元的处罚。5月18日上午,新浪微博网友“年少情深似海”发布的一条微博内容称:“泰顺县人民医院结核科叶医生,一边看病人一边抽烟。结核病本就应该戒烟戒酒,直接让来这里看结核病的人吸他的二手烟……”微博中还附有5段小视频,视频中地点显示为结核病门诊,其中一名

Lancet infect dis:大规模流动人口可增加城市结核病发病率!

随着农村人口到城市的大规模内部迁移,给中国的结核病控制 带来了新的挑战。现有研究人员结合基因组、空间和流行病学数据,对结核病在有大量流动人口的城市环境中的动态进行调查。研究人员在上海松江进行一以人群为基础的研究。利用全基因组测序区分有相同的可变数字串联重复(VNTR)模式的M结核分枝杆菌的表观遗传群,并分析居住的邻近性与基因组聚集的M型结核杆菌的风险之间的关系。最后,利用基因组、空间和流行病学数据

Front Immunol:研究揭示了结核病治疗的新靶点

结核分枝杆菌是结核病(TB)的病原体,主要引起肺损伤和结节。尽管通常认为巨噬细胞是携带结核分枝杆菌的主要细胞,但新的证据表明嗜中性粒细胞迅速募集到受感染的肺部。结核分枝杆菌本身或其早期分泌的抗原靶蛋白6(ESAT-6)可以诱导嗜中性粒细胞胞外诱集剂(NETs)的形成。然而,NETs仅能捕获却无法杀死分枝杆菌,其在分枝杆菌发病机制中的作用尚不清楚。在这里,我们报告了一种新的结核分枝杆菌细胞外因子,双

Infect Dis:结核病影响家庭的灾难性总成本及其决定因素

除了强加于受影响的家庭将经济负担之外,与结核病相关的高成本也会造成资源获取和依从性障碍。这凸显了实现消除结核病战略目标的紧迫

彭丽媛出席世界防治结核病日主题宣传活动

世界卫生组织结核病/艾滋病防治亲善大使彭丽媛出席世界防治结核病日主题宣传活动。